Potassium voltage-gated channel Shaker (Shaker) (Shaker)

The Shaker potassium channel is a prototypical voltage-gated ion channel originally identified in Drosophila melanogaster, where mutations cause a characteristic shaking phenotype due to defective repolarization (Jan & Jan, 1997, Nature [1]). It serves as the foundational model for the Kv1 (Shaker-related) family of channels in mammals, which are critical for regulating neuronal excitability and the repolarization phase of action potentials (Wulff et al., 2009, Nat Rev Drug Discov [2]). The Shaker-IR (Inactivation Removed) variant is a widely used laboratory tool in which the N-terminal 'ball-and-chain' mechanism is deleted to allow for the study of steady-state conductance and pore properties without fast inactivation (Hoshi et al., 1990, Science [3]). In humans, orthologs such as Kv1.1 (KCNA1) and Kv1.3 (KCNA3) are significant therapeutic targets; Kv1.1 mutations are linked to episodic ataxia and epilepsy, while Kv1.3 is a key target for modulating T-cell mediated autoimmune responses (Cahalan & Chandy, 2009, Immunol Rev [4]). Pharmacological agents targeting these channels include small molecule blockers like 4-aminopyridine (Dalfampridine) and various peptide toxins like Charybdotoxin, which are used to treat neuromuscular disorders or study channel biophysics (PubChem, CID 1727 [5]).

Other names

ShShaker-IRKv1Drosophila Shaker channelPotassium voltage-gated channel subfamily A

Drugs targeting this channel typically function as pore blockers that physically obstruct the ion conduction pathway or as gating modifiers that shift the voltage-dependence of channel activation (Catterall, 2010, Cold Spring Harb Perspect Biol [6]).